Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Airway diseases
  • Open access
  • Published:

Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease

Egyptian Journal of Bronchology volume 10, pages 46–51 (2016)Cite this article

Abstract

Background

Mean platelet volume (MPV) is affected by inflammation in many conditions, such as in inflammatory bowel diseases, rheumatoid arthritis, and ankylosing spondylitis. Conflicting reports exist about its value in stable and exacerbating chronic obstructive pulmonary disease (COPD).

Objective

The aim of the present study was to find out whether there was a significant change in the MPV during acute exacerbation of COPD compared with smokers and healthy controls.

Patients and methods

The study was carried out on 135 adult patients of both sexes (77 men and 58 women), who presented to Alexandria Main University Hospital. Patients were categorized into three groups of 45 patients each; patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) made up group I, healthy smokers without COPD made up group II, and healthy controls made up group III.

Results

MPV values were 8.34 ± 0.95 and 9.28 ± 0.67 fl in patients with acute exacerbation of COPD and in smokers, respectively. MPV values in the control group were 9.12 ± 0.60 fl. MPV values were significantly lower in patients of acute exacerbation than in smokers and controls (both, P < 0.001). A positive correlation was found between MPV and measured forced expiratory volume at first second (FEV1), C-reactive protein, and total leukocytic count in total sample.

Conclusion

MPV was found to be decreased in acute exacerbations of COPD compared with smokers and healthy controls. Evaluation of MPV in COPD exacerbation may indicate systemic inflammation. Thus, MPV may be used as a negative acute-phase reactant in COPD exacerbation.

References

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD: updated 2015. Belgium: Global Initiative for Chronic Obstructive Lung Disease Inc.; 2015. Available at: http://www.goldcopd.org/.

    Google Scholar 

  2. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22:672–688.

    PubMed  CAS  Google Scholar 

  3. Donaldson GC, Wilkinson TM, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:446–452.

    PubMed  Google Scholar 

  4. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22:1561–1571.

    PubMed  CAS  Google Scholar 

  5. Becchi C, Al Malyan M, Fabbri LP, Marsili M, Boddi V, Boncinelli S. Mean platelet volume trend in sepsis: is it a useful parameter?. Minerva Anestesiol. 2006; 72:749–756.

    PubMed  CAS  Google Scholar 

  6. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des 2011; 17:47–58.

    PubMed  CAS  Google Scholar 

  7. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8:148–156.

    PubMed  CAS  Google Scholar 

  8. Ilhan D, Ozbabalik D, Gulcan E, Ozdemir O, Gülbaçs Z. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke. Neurologist 2010; 16:188–191.

    PubMed  Google Scholar 

  9. Erikçi AA, Muhçu M, Dündar O, Oztürk A. Could mean platelet volume be a predictive marker for gestational diabetes mellitus?. Hematology 2008; 13:46–48.

    PubMed  Google Scholar 

  10. Canpolat F, Akpinar H, Eskioğlu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 2010; 29:325–328.

    PubMed  Google Scholar 

  11. Coban E, Adanir H. Platelet activation in patients with Familial Mediterranean Fever. Platelets 2008; 19:405–408.

    PubMed  CAS  Google Scholar 

  12. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96:776–781.

    PubMed  CAS  Google Scholar 

  13. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010; 21:122–125.

    PubMed  CAS  Google Scholar 

  14. Bansal R, Gupta HL, Goel A, Yadav M. Association of increased platelet volume in patients of chronic obstructive pulmonary disease: clinical implications. J Indian Acad Clin Med 2002; 3:169–172.

    Google Scholar 

  15. Onder I, Topcu S, Dökmetas HS, Türkay C, Seyfikli Z. Platelet aggregation size and volume in chronic obstructive pulmonary disease. Mater Med Pol 1997; 29: 11–13.

    PubMed  CAS  Google Scholar 

  16. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7:157–161.

    PubMed  CAS  Google Scholar 

  17. Varol E, Icli A, Kocyigit S, Erdogan D, Ozaydin M, Dogan A. Effect of smoking cessation on mean platelet volume. Clin Appl Thromb Hemost 2013; 19:315–319.

    PubMed  Google Scholar 

  18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force Standardisation of spirometry. Eur Respir J 2005; 26:319–338.

    CAS  PubMed  Google Scholar 

  19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:S5–40.

    Google Scholar 

  20. Parker CM, Voduc N, Aaron SD, Webb KA, O’Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005; 26:420–428.

    PubMed  CAS  Google Scholar 

  21. Barberà JA, Roca J, Ferrer A, Félez MA, Díaz O, Roger N, Rodriguez-Roisin R. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1285–1291.

    PubMed  Google Scholar 

  22. MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:530–535.

    PubMed  PubMed Central  Google Scholar 

  23. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84:210–215.

    CAS  PubMed  Google Scholar 

  24. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van’t Veer C, Buurman WA, Wouters EF. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56:721–726.

    PubMed  PubMed Central  CAS  Google Scholar 

  25. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc. 2007; 4:626–634.

    CAS  PubMed  Google Scholar 

  27. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn 2012; 122:284–290.

    PubMed  CAS  Google Scholar 

  28. Wang RT, Li JY, Cao ZG, Li Y. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology 2013; 18:1244–1248.

    PubMed  Google Scholar 

  29. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax 1991; 46:504–507.

    PubMed  PubMed Central  CAS  Google Scholar 

  30. Shen D, Wang Y. Effects of hypoxia on platelet activation in pilots. Aviat Space Environ Med1994; 65:646–648.

    PubMed  CAS  Google Scholar 

  31. Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, et al. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology 2013; 64:535–539.

    PubMed  CAS  Google Scholar 

  32. Cui H, Liu L, Wei Z, Wang D, Hu Y, Hu G, Fan L. Clinical value of mean platelet volume for impaired cardiopulmonary function in very old male patients with chronic obstructive pulmonary disease. Arch Gerontol Geriatr 2012; 54:e109–e112.

    PubMed  Google Scholar 

  33. Biljak VR, Pancirov D, Cepelak I, Popović-Grle S, Stjepanović G, Grubišić TŽ. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets 2011; 22:466–470.

    PubMed  CAS  Google Scholar 

  34. Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011; 66:769–774.

    PubMed  Google Scholar 

  35. Ferroni P, Basili S, Martini F, Vieri M, Labbadia G, Cordova C, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med 2000; 48:21–27.

    PubMed  CAS  Google Scholar 

  36. De Castro J, Hernández-Hernández A, Rodríguez MC, Sardina JL, Llanillo M, Sánchez-Yagüe J. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. Platelets 2007; 18:43–51.

    PubMed  Google Scholar 

  37. Davi G, Basili S, Vieri M, Cipollone F, Santarone S, Alessandri C, et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease The Chronic Obstructive Bronchitis and Haemostasis Study Group. Am J Respir Crit Care Med 1997; 156:1794–1799.

    PubMed  CAS  Google Scholar 

  38. Cordova C, Musca A, Violi F, Alessandri C, Perrone A, Balsano F. Platelet hyperfunction in patients with chronic airways obstruction. Eur J Respir Dis. 1985; 66:9–12.

    PubMed  CAS  Google Scholar 

  39. Patrono C. Thromboxane synthesis inhibitors and receptor antagonists. Thromb Res Suppl 1990; 11: :15–23.

    PubMed  CAS  Google Scholar 

  40. Arslan E, Yakar T, Yavaşoğlu I. The effect of smoking on mean platelet volume and lipid profile in young male subjects. Anadolu Kardiyol Derg 2008; 8:422–425.

    PubMed  Google Scholar 

  41. Helmy TA, Baess AI, Monsif DAA, Elnasharty AA. Role of C-reactive protein and interleukin-6 in predicting the prognosis of ICU-admitted patients with acute exacerbation of COPD. Egypt J Chest Dis Tuberc 2014; 63:829–835.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Critical Care Medicine, Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt

    Tamer A. Helmy & Ahmad A. Algarahi

  2. Departments of Chest Diseases, Alexandria Faculty of Medicine, Alexandria University, Alexandria, 21131, Egypt

    Ayman I. Baess PhD (MD)

Authors
  1. Tamer A. Helmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayman I. Baess PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmad A. Algarahi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayman I. Baess PhD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Helmy, T.A., Baess, A.I. & Algarahi, A.A. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Egypt J Bronchol 10, 46–51 (2016). https://doi.org/10.4103/1687-8426.176772

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.176772

Keywords